Humana Reaffirms 2025 Earnings Guidance in June Meetings

Humana ( (HUM) ) has issued an announcement.

Humana Inc. announced that its senior management will meet with investors and analysts throughout June 2025 to reaffirm its earnings guidance for the year ending December 31, 2025. The company projects diluted earnings per share of approximately $14.68 and adjusted earnings per share of approximately $16.25, consistent with its previous guidance. Humana will also host an Investor Conference on June 16, 2025, to discuss its strategic direction and financial performance. The use of Adjusted EPS, which differs from GAAP EPS, is intended to provide a more comprehensive view of the company’s core operating performance.

The most recent analyst rating on (HUM) stock is a Hold with a $253.00 price target. To see the full list of analyst forecasts on Humana stock, see the HUM Stock Forecast page.

Spark’s Take on HUM Stock

According to Spark, TipRanks’ AI Analyst, HUM is a Outperform.

Humana’s strong financial performance and recent corporate events underpin a favorable outlook. While valuation remains fair and the company shows operational strength, technical analysis suggests caution due to lack of upward momentum. External uncertainties from regulatory challenges and litigation also temper the overall score.

To see Spark’s full report on HUM stock, click here.

More about Humana

Humana Inc. operates in the healthcare industry, providing health insurance and related services. The company focuses on offering Medicare plans, group health insurance, and specialty benefits, with a strong emphasis on improving healthcare outcomes and affordability for its members.

Average Trading Volume: 1,746,292

Technical Sentiment Signal: Sell

Current Market Cap: $28.14B

See more data about HUM stock on TipRanks’ Stock Analysis page.